"Data suggest new class of drug may be potent against genital herpes"
Filed under Research
A new drug, called pritelivir, may offer a new treatment option for patients with genital herpes, a new industry-sponsored – study led by University of Washington researchers has found. The study appears in this week’s issue of the New England Journal of Medicine. The lead author is Anna Wald, M.D., professor of medicine, epidemiology, and laboratory medicine, and medical director at the Virology Research Clinic at the University of Washington.